3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Prostatic Neoplasms
3
Uterine Cervical Dysplasia
2
Thyroid Nodule
2
Sarcoma
2
Papillomavirus Infections
2
Melanoma
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Spinal Cord Compression
1
Recurrence
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Neoplasms
1
Liver Neoplasms
1
Hyperthyroidism
1
HIV Infections
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Gastrointestinal Neoplasms
1
Interventions
Carboplatin
5
Paclitaxel
4
pembrolizumab
3
Educational Status
3
niraparib
2
anlotinib
2
Therapeutic Touch
2
Pemetrexed
2
Palliative Care
2
Nivolumab
2
Methods
2
Gemcitabine
2
Early Intervention, Educational
2
Bevacizumab
2
temsirolimus
1
rucaparib
1
relacorilant
1
olaparib
1
nintedanib
1
nilotinib
1
liposomal doxorubicin
1
lenvatinib
1
fosaprepitant
1
atezolizumab
1
argatroban
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Topotecan
1
Thrombopoietin
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Genital Neoplasms, Female
×
Transurethral Resection of Prostate
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled